Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis

Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsoni...

Full description

Saved in:
Bibliographic Details
Published in:Cell reports (Cambridge) Vol. 23; no. 13; pp. 3946 - 3959.e6
Main Authors: Matlung, Hanke L., Babes, Liane, Zhao, Xi Wen, van Houdt, Michel, Treffers, Louise W., van Rees, Dieke J., Franke, Katka, Schornagel, Karin, Verkuijlen, Paul, Janssen, Hans, Halonen, Pasi, Lieftink, Cor, Beijersbergen, Roderick L., Leusen, Jeanette H.W., Boelens, Jaap J., Kuhnle, Ingrid, van der Werff Ten Bosch, Jutte, Seeger, Karl, Rutella, Sergio, Pagliara, Daria, Matozaki, Takashi, Suzuki, Eiji, Menke-van der Houven van Oordt, Catharina Willemien, van Bruggen, Robin, Roos, Dirk, van Lier, Rene A.W., Kuijpers, Taco W., Kubes, Paul, van den Berg, Timo K.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 26.06.2018
Elsevier
Subjects:
ISSN:2211-1247, 2211-1247
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPα checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPα interactions. [Display omitted] •Neutrophils kill antibody-opsonized cancer cells by a process called trogoptosis•Cancer cell plasma membrane ingestion by neutrophils is instrumental in trogoptosis•Trogoptosis by neutrophils is further enhanced by CD47-SIRPα checkpoint inhibition Matlung et al. identify trogoptosis as an immune cell-mediated mechanism of cytotoxicity, demonstrating that neutrophil-mediated destruction of antibody-opsonized cancer cells occurs through a specific process that is distinct from that used by other immune cells.
AbstractList Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPα checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPα interactions. [Display omitted] •Neutrophils kill antibody-opsonized cancer cells by a process called trogoptosis•Cancer cell plasma membrane ingestion by neutrophils is instrumental in trogoptosis•Trogoptosis by neutrophils is further enhanced by CD47-SIRPα checkpoint inhibition Matlung et al. identify trogoptosis as an immune cell-mediated mechanism of cytotoxicity, demonstrating that neutrophil-mediated destruction of antibody-opsonized cancer cells occurs through a specific process that is distinct from that used by other immune cells.
Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPα checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPα interactions. : Matlung et al. identify trogoptosis as an immune cell-mediated mechanism of cytotoxicity, demonstrating that neutrophil-mediated destruction of antibody-opsonized cancer cells occurs through a specific process that is distinct from that used by other immune cells. Keywords: antibody-dependent cellular cytotoxicity, neutrophils, CD47-SIRPα interaction, trogocytosis, trogoptosis
Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPα checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPα interactions.Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPα checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPα interactions.
Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPα checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPα interactions.
Author Verkuijlen, Paul
Beijersbergen, Roderick L.
van Bruggen, Robin
van Rees, Dieke J.
Menke-van der Houven van Oordt, Catharina Willemien
van Lier, Rene A.W.
Schornagel, Karin
Seeger, Karl
Boelens, Jaap J.
Leusen, Jeanette H.W.
Matlung, Hanke L.
Kuhnle, Ingrid
van der Werff Ten Bosch, Jutte
Franke, Katka
Lieftink, Cor
Kubes, Paul
Kuijpers, Taco W.
Roos, Dirk
Rutella, Sergio
Babes, Liane
Halonen, Pasi
van den Berg, Timo K.
Treffers, Louise W.
Pagliara, Daria
Zhao, Xi Wen
Suzuki, Eiji
van Houdt, Michel
Janssen, Hans
Matozaki, Takashi
Author_xml – sequence: 1
  givenname: Hanke L.
  surname: Matlung
  fullname: Matlung, Hanke L.
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 2
  givenname: Liane
  surname: Babes
  fullname: Babes, Liane
  organization: Immunology Research Group, University of Calgary, Calgary, Alberta, Canada
– sequence: 3
  givenname: Xi Wen
  surname: Zhao
  fullname: Zhao, Xi Wen
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 4
  givenname: Michel
  surname: van Houdt
  fullname: van Houdt, Michel
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 5
  givenname: Louise W.
  surname: Treffers
  fullname: Treffers, Louise W.
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 6
  givenname: Dieke J.
  surname: van Rees
  fullname: van Rees, Dieke J.
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 7
  givenname: Katka
  surname: Franke
  fullname: Franke, Katka
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 8
  givenname: Karin
  surname: Schornagel
  fullname: Schornagel, Karin
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 9
  givenname: Paul
  surname: Verkuijlen
  fullname: Verkuijlen, Paul
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 10
  givenname: Hans
  surname: Janssen
  fullname: Janssen, Hans
  organization: Division of Cell Biology, the Netherlands Cancer Institute, Amsterdam, the Netherlands
– sequence: 11
  givenname: Pasi
  surname: Halonen
  fullname: Halonen, Pasi
  organization: Division of Molecular Carcinogenesis and the NKI Robotics and Screening Center, the Netherlands Cancer Institute, Amsterdam, the Netherlands
– sequence: 12
  givenname: Cor
  surname: Lieftink
  fullname: Lieftink, Cor
  organization: Division of Molecular Carcinogenesis and the NKI Robotics and Screening Center, the Netherlands Cancer Institute, Amsterdam, the Netherlands
– sequence: 13
  givenname: Roderick L.
  surname: Beijersbergen
  fullname: Beijersbergen, Roderick L.
  organization: Division of Molecular Carcinogenesis and the NKI Robotics and Screening Center, the Netherlands Cancer Institute, Amsterdam, the Netherlands
– sequence: 14
  givenname: Jeanette H.W.
  surname: Leusen
  fullname: Leusen, Jeanette H.W.
  organization: Immunotherapy Laboratory, Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
– sequence: 15
  givenname: Jaap J.
  surname: Boelens
  fullname: Boelens, Jaap J.
  organization: U-DANCE, Laboratory for Translational Immunology, UMC Utrecht, Utrecht, the Netherlands
– sequence: 16
  givenname: Ingrid
  surname: Kuhnle
  fullname: Kuhnle, Ingrid
  organization: Department of Pediatrics, University Medicine Göttingen, Göttingen, Germany
– sequence: 17
  givenname: Jutte
  surname: van der Werff Ten Bosch
  fullname: van der Werff Ten Bosch, Jutte
  organization: Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels, Belgium
– sequence: 18
  givenname: Karl
  surname: Seeger
  fullname: Seeger, Karl
  organization: Department of Pediatric Oncology/Hematology, Otto-Heubner-Center for Pediatric and Adolescent Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany
– sequence: 19
  givenname: Sergio
  surname: Rutella
  fullname: Rutella, Sergio
  organization: Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar
– sequence: 20
  givenname: Daria
  surname: Pagliara
  fullname: Pagliara, Daria
  organization: Department of Pediatric Hematology/Oncology, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy
– sequence: 21
  givenname: Takashi
  surname: Matozaki
  fullname: Matozaki, Takashi
  organization: Department of Biochemistry and Molecular Biology, Division of Molecular and Cellular Signaling, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
– sequence: 22
  givenname: Eiji
  surname: Suzuki
  fullname: Suzuki, Eiji
  organization: Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan
– sequence: 23
  givenname: Catharina Willemien
  surname: Menke-van der Houven van Oordt
  fullname: Menke-van der Houven van Oordt, Catharina Willemien
  organization: Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands
– sequence: 24
  givenname: Robin
  surname: van Bruggen
  fullname: van Bruggen, Robin
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 25
  givenname: Dirk
  surname: Roos
  fullname: Roos, Dirk
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 26
  givenname: Rene A.W.
  surname: van Lier
  fullname: van Lier, Rene A.W.
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 27
  givenname: Taco W.
  surname: Kuijpers
  fullname: Kuijpers, Taco W.
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 28
  givenname: Paul
  surname: Kubes
  fullname: Kubes, Paul
  organization: Immunology Research Group, University of Calgary, Calgary, Alberta, Canada
– sequence: 29
  givenname: Timo K.
  surname: van den Berg
  fullname: van den Berg, Timo K.
  email: t.k.vandenberg@sanquin.nl
  organization: Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29949776$$D View this record in MEDLINE/PubMed
BookMark eNpNkU9v1DAQxS3Uiv6h3wChHLkkeJxZx76AqhUtFVV7KWfLsSfFq2wc7Gyl5dPjdgtiLh5ZPz37vXfGjqY4EWPvgTfAQX7aNI7GRHMjOKiGrxquxBt2KgRADQK7o__2E3aR84aXkRxA41t2IrRG3XXylH25o92S4vwzjLn6HsaxupyW0Ee_r-_nHKfwm3y1tpOjVK1pLFC_rx5SfIzzEnPI79jxYMdMF6_nOftx9fVh_a2-vb--WV_e1h6VWuqW9OCU8y2SFkoqFFoiDR7tSgnheQ9aDx2XDkgOuELpEcgqOXDqcHCyPWc3B10f7cbMKWxt2ptog3m5iOnR2LQEN5Ip1lQnLKLUgORkrzreIm89IthO6aL18aA1p_hrR3kx25BLnqOdKO6yEVwCQiuVKuiHV3TXb8n_e_hvgAX4fAComH8KlEx2gUpcPiRyS_ldMMDNc2lmYw6lmefSDF-ZUlr7Bz4tico
ContentType Journal Article
Copyright 2018
Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2018
– notice: Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1016/j.celrep.2018.05.082
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2211-1247
EndPage 3959.e6
ExternalDocumentID oai_doaj_org_article_949872a446914ec6b8703403d441a789
29949776
S2211124718308635
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
0SF
4.4
457
53G
5VS
6I.
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AAKRW
AALRI
AAUCE
AAXJY
AAXUO
ABMAC
ABMWF
ACGFO
ACGFS
ADBBV
ADEZE
AENEX
AEXQZ
AFTJW
AGHFR
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BCNDV
DIK
EBS
EJD
FCP
FDB
FRP
GROUPED_DOAJ
GX1
IXB
KQ8
M41
M48
NCXOZ
O-L
O9-
OK1
RCE
RIG
ROL
SSZ
AAMRU
AAYWO
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AIGII
AKBMS
AKRWK
AKYEP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-d488t-3e9fc8cd34e9286842964efd4a5822d0b199f706c1e6f4546d41ea86f0e74fc63
IEDL.DBID DOA
ISICitedReferencesCount 313
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000436517100023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2211-1247
IngestDate Fri Oct 03 12:53:49 EDT 2025
Thu Sep 04 15:22:07 EDT 2025
Mon Jul 21 06:05:59 EDT 2025
Tue May 16 22:30:57 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 13
Keywords trogocytosis
trogoptosis
antibody-dependent cellular cytotoxicity
CD47-SIRPα interaction
neutrophils
Language English
License This is an open access article under the CC BY-NC-ND license.
Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-d488t-3e9fc8cd34e9286842964efd4a5822d0b199f706c1e6f4546d41ea86f0e74fc63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/949872a446914ec6b8703403d441a789
PMID 29949776
PQID 2061413688
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_949872a446914ec6b8703403d441a789
proquest_miscellaneous_2061413688
pubmed_primary_29949776
elsevier_sciencedirect_doi_10_1016_j_celrep_2018_05_082
PublicationCentury 2000
PublicationDate 2018-06-26
PublicationDateYYYYMMDD 2018-06-26
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-26
  day: 26
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell reports (Cambridge)
PublicationTitleAlternate Cell Rep
PublicationYear 2018
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References van Beek, Zarate, van Bruggen, Schornagel, Tool, Matozaki, Kraal, Roos, van den Berg (bib56) 2012; 2
Musolino, Naldi, Bortesi, Pezzuolo, Capelletti, Missale, Laccabue, Zerbini, Camisa, Bisagni (bib32) 2008; 26
Herrero-Turrión, Calafat, Janssen, Fukuda, Mollinedo (bib19) 2008; 181
Glennie, van de Winkel (bib15) 2003; 8
van Egmond, Bakema (bib57) 2013; 23
Yi, Li, Chen, Wu, An, Xu, Hu, Lowell, Cyster (bib64) 2015; 43
Strome, Sausville, Mann (bib47) 2007; 12
Martínez-Martín, Fernández-Arenas, Cemerski, Delgado, Turner, Heuser, Irvine, Huang, Bustelo, Shaw, Alarcón (bib27) 2011; 35
Velmurugan, Challa, Ram, Ober, Ward (bib62) 2016; 15
Borregaard, Sørensen, Theilgaard-Mönch (bib4) 2007; 28
DiLillo, Ravetch (bib11) 2015; 161
Zhu, Gai, Opel, Kwan, Surana, Mihm, Kauke, Moynihan, Angelini, Williams (bib69) 2015; 27
de Saint Basile, Ménasché, Fischer (bib10) 2010; 10
van Spriel, van Ojik, Bakker, Jansen, van de Winkel (bib61) 2003; 101
Jaiswal, Jamieson, Pang, Park, Chao, Majeti, Traver, van Rooijen, Weissman (bib21) 2009; 138
Kuijpers, Kuijpers, Zeijlemaker, Lucas, van Lier, Miedema (bib23) 1990; 144
Ralston, Solga, Mackey-Lawrence, Somlata, Bhattacharya, Petri (bib36) 2014; 508
Hawkins, Stephens, Suire, Wilson (bib17) 2010; 346
Sancho, Mourão-Sá, Joffre, Schulz, Rogers, Pennington, Carlyle, Reis e Sousa (bib41) 2008; 118
Montalvao, Garcia, Celli, Breart, Deguine, Van Rooijen, Bousso (bib31) 2013; 123
Calafat, Janssen, Ståhle-Bäckdahl, Zuurbier, Knol, Egesten (bib6) 1997; 90
Tabiasco, Espinosa, Hudrisier, Joly, Fournié, Vercellone (bib49) 2002; 32
Dustin, Long (bib12) 2010; 235
Majeti, Chao, Alizadeh, Pang, Jaiswal, Gibbs, van Rooijen, Weissman (bib26) 2009; 138
Somlata, Nakada-Tsukui, Nozaki (bib44) 2017; 8
Weiskopf, Ring, Ho, Volkmer, Levin, Volkmer, Ozkan, Fernhoff, van de Rijn, Weissman, Garcia (bib63) 2013; 341
Inagaki, Yamao, Noguchi, Matozaki, Fukunaga, Takada, Hosooka, Akira, Kasuga (bib20) 2000; 19
Ahrens, Zelenay, Sancho, Hanč, Kjær, Feest, Fletcher, Durkin, Postigo, Skehel (bib1) 2012; 36
Soto-Pantoja, Miller, Frazier, Roberts (bib45) 2012; 109
Kuijpers, Tool, van der Schoot, Ginsel, Onderwater, Roos, Verhoeven (bib24) 1991; 78
Roos, van Bruggen, Meischl (bib39) 2003; 5
Zhao, Matlung, Kuijpers, van den Berg (bib67) 2012; 109
Ring, Herndler-Brandstetter, Weiskopf, Shan, Volkmer, George, Lietzenmayer, McKenna, Naik, McCarty (bib38) 2017; 114
Chao, Jaiswal, Weissman-Tsukamoto, Alizadeh, Gentles, Volkmer, Weiskopf, Willingham, Raveh, Park (bib8) 2010; 2
Zhao, Kuijpers, van den Berg (bib66) 2012; 119
Nimmerjahn, Gordan, Lux (bib34) 2015; 36
Liu, Pu, Cron, Deng, Kline, Frazier, Xu, Peng, Fu, Xu (bib25) 2015; 21
Nimmerjahn, Ravetch (bib33) 2008; 8
Soto-Pantoja, Terabe, Ghosh, Ridnour, DeGraff, Wink, Berzofsky, Roberts (bib46) 2014; 74
Zhao, Gazendam, Drewniak, van Houdt, Tool, van Hamme, Kustiawan, Meijer, Janssen, Russell (bib68) 2013; 122
Eruslanov, Bhojnagarwala, Quatromoni, Stephen, Ranganathan, Deshpande, Akimova, Vachani, Litzky, Hancock (bib13) 2014; 124
van den Berg, van Bruggen (bib59) 2015; 43
Valgardsdottir, Cattaneo, Klein, Introna, Figliuzzi, Golay (bib55) 2017; 129
Matzinger (bib28) 2002; 296
Tintinger, Steel, Anderson (bib51) 2005; 141
Hernandez-Ilizaliturri, Jupudy, Ostberg, Oflazoglu, Huberman, Repasky, Czuczman (bib18) 2003; 9
Rosseau, Selhorst, Wiechmann, Leissner, Maus, Mayer, Grimminger, Seeger, Lohmeyer (bib40) 2000; 164
Segal (bib42) 2005; 23
Oldham, Dillman (bib35) 2008; 26
Treffers, Zhao, van der Heijden, Nagelkerke, van Rees, Gonzalez, Geissler, Verkuijlen, van Houdt, de Boer (bib53) 2018; 48
Bryceson, Long (bib5) 2008; 20
Mócsai, Ruland, Tybulewicz (bib30) 2010; 10
Siders, Shields, Garron, Hu, Boutin, Shankara, Weber, Roberts, Kaplan (bib43) 2010; 51
Topalian, Drake, Pardoll (bib52) 2015; 27
Barclay, van den Berg (bib3) 2014; 32
Chen, Nuñez (bib9) 2010; 10
Reeves, Lu, Jacobs, Messina, Bolsover, Gabella, Potma, Warley, Roes, Segal (bib37) 2002; 416
Meeths, Entesarian, Al-Herz, Chiang, Wood, Al-Ateeqi, Almazan, Boelens, Hasle, Ifversen (bib29) 2010; 116
Joly, Hudrisier (bib22) 2003; 4
Suzuki, Kataoka, Hirata, Kawaguchi, Nishie, Haga, Toi (bib48) 2015; 15
Fevre, Bestebroer, Mebius, de Haas, van Strijp, Fitzgerald, Haas (bib14) 2014; 16
Albanesi, Mancardi, Jönsson, Iannascoli, Fiette, Di Santo, Lowell, Bruhns (bib2) 2013; 122
Tseng, Volkmer, Willingham, Contreras-Trujillo, Fathman, Fernhoff, Seita, Inlay, Weiskopf, Miyanishi, Weissman (bib54) 2013; 110
Taylor, Lindorfer (bib50) 2015; 125
Gül, Babes, Siegmund, Korthouwer, Bögels, Braster, Vidarsson, ten Hagen, Kubes, van Egmond (bib16) 2014; 124
Zhao, van Beek, Schornagel, van der Maaden, van Houdt, Otten, Finetti, van Egmond, Matozaki, Kraal (bib65) 2011; 108
Chao, Alizadeh, Tang, Myklebust, Varghese, Gill, Jan, Cha, Chan, Tan (bib7) 2010; 142
van Spriel, Leusen, van Egmond, Dijkman, Assmann, Mayadas, van de Winkel (bib60) 2001; 97
van de Vijver, Maddalena, Sanal, Holland, Uzel, Madkaikar, de Boer, van Leeuwen, Köker, Parvaneh (bib58) 2012; 48
References_xml – volume: 10
  start-page: 387
  year: 2010
  end-page: 402
  ident: bib30
  article-title: The SYK tyrosine kinase: a crucial player in diverse biological functions
  publication-title: Nat. Rev. Immunol.
– volume: 43
  start-page: 622
  year: 2015
  end-page: 624
  ident: bib59
  article-title: Loss of CD47 makes dendritic cells see red
  publication-title: Immunity
– volume: 32
  start-page: 1502
  year: 2002
  end-page: 1508
  ident: bib49
  article-title: Active trans-synaptic capture of membrane fragments by natural killer cells
  publication-title: Eur. J. Immunol.
– volume: 28
  start-page: 340
  year: 2007
  end-page: 345
  ident: bib4
  article-title: Neutrophil granules: a library of innate immunity proteins
  publication-title: Trends Immunol.
– volume: 5
  start-page: 1307
  year: 2003
  end-page: 1315
  ident: bib39
  article-title: Oxidative killing of microbes by neutrophils
  publication-title: Microbes Infect.
– volume: 27
  start-page: 450
  year: 2015
  end-page: 461
  ident: bib52
  article-title: Immune checkpoint blockade: a common denominator approach to cancer therapy
  publication-title: Cancer Cell
– volume: 122
  start-page: 3160
  year: 2013
  end-page: 3164
  ident: bib2
  article-title: Neutrophils mediate antibody-induced antitumor effects in mice
  publication-title: Blood
– volume: 108
  start-page: 18342
  year: 2011
  end-page: 18347
  ident: bib65
  article-title: CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 114
  start-page: E10578
  year: 2017
  end-page: E10585
  ident: bib38
  article-title: Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 32
  start-page: 25
  year: 2014
  end-page: 50
  ident: bib3
  article-title: The Interaction Between Signal Regulatory Protein Alpha (SIRPalpha) and CD47: Structure, Function, and Therapeutic Target
  publication-title: Annu. Rev. Immunol.
– volume: 124
  start-page: 812
  year: 2014
  end-page: 823
  ident: bib16
  article-title: Macrophages eliminate circulating tumor cells after monoclonal antibody therapy
  publication-title: J. Clin. Invest.
– volume: 35
  start-page: 208
  year: 2011
  end-page: 222
  ident: bib27
  article-title: T cell receptor internalization from the immunological synapse is mediated by TC21 and RhoG GTPase-dependent phagocytosis
  publication-title: Immunity
– volume: 36
  start-page: 635
  year: 2012
  end-page: 645
  ident: bib1
  article-title: F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells
  publication-title: Immunity
– volume: 21
  start-page: 1209
  year: 2015
  end-page: 1215
  ident: bib25
  article-title: CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
  publication-title: Nat. Med.
– volume: 36
  start-page: 325
  year: 2015
  end-page: 336
  ident: bib34
  article-title: FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities
  publication-title: Trends Immunol.
– volume: 181
  start-page: 3793
  year: 2008
  end-page: 3803
  ident: bib19
  article-title: Rab27a regulates exocytosis of tertiary and specific granules in human neutrophils
  publication-title: J. Immunol.
– volume: 78
  start-page: 1105
  year: 1991
  end-page: 1111
  ident: bib24
  article-title: Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation
  publication-title: Blood
– volume: 138
  start-page: 286
  year: 2009
  end-page: 299
  ident: bib26
  article-title: CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells
  publication-title: Cell
– volume: 26
  start-page: 1774
  year: 2008
  end-page: 1777
  ident: bib35
  article-title: Monoclonal antibodies in cancer therapy: 25 years of progress
  publication-title: J. Clin. Oncol.
– volume: 8
  start-page: 503
  year: 2003
  end-page: 510
  ident: bib15
  article-title: Renaissance of cancer therapeutic antibodies
  publication-title: Drug Discov. Today
– volume: 508
  start-page: 526
  year: 2014
  end-page: 530
  ident: bib36
  article-title: Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion
  publication-title: Nature
– volume: 346
  start-page: 183
  year: 2010
  end-page: 202
  ident: bib17
  article-title: PI3K signaling in neutrophils
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 341
  start-page: 88
  year: 2013
  end-page: 91
  ident: bib63
  article-title: Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies
  publication-title: Science
– volume: 110
  start-page: 11103
  year: 2013
  end-page: 11108
  ident: bib54
  article-title: Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 416
  start-page: 291
  year: 2002
  end-page: 297
  ident: bib37
  article-title: Killing activity of neutrophils is mediated through activation of proteases by K+ flux
  publication-title: Nature
– volume: 141
  start-page: 191
  year: 2005
  end-page: 200
  ident: bib51
  article-title: Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control
  publication-title: Clin. Exp. Immunol.
– volume: 116
  start-page: 2635
  year: 2010
  end-page: 2643
  ident: bib29
  article-title: Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2
  publication-title: Blood
– volume: 90
  start-page: 1255
  year: 1997
  end-page: 1266
  ident: bib6
  article-title: Human monocytes and neutrophils store transforming growth factor-alpha in a subpopulation of cytoplasmic granules
  publication-title: Blood
– volume: 27
  start-page: 489
  year: 2015
  end-page: 501
  ident: bib69
  article-title: Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2
  publication-title: Cancer Cell
– volume: 101
  start-page: 253
  year: 2003
  end-page: 258
  ident: bib61
  article-title: Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma
  publication-title: Blood
– volume: 10
  start-page: 826
  year: 2010
  end-page: 837
  ident: bib9
  article-title: Sterile inflammation: sensing and reacting to damage
  publication-title: Nat. Rev. Immunol.
– volume: 235
  start-page: 24
  year: 2010
  end-page: 34
  ident: bib12
  article-title: Cytotoxic immunological synapses
  publication-title: Immunol. Rev.
– volume: 26
  start-page: 1789
  year: 2008
  end-page: 1796
  ident: bib32
  article-title: Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
  publication-title: J. Clin. Oncol.
– volume: 74
  start-page: 6771
  year: 2014
  end-page: 6783
  ident: bib46
  article-title: CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy
  publication-title: Cancer Res.
– volume: 125
  start-page: 762
  year: 2015
  end-page: 766
  ident: bib50
  article-title: Fcγ-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments
  publication-title: Blood
– volume: 138
  start-page: 271
  year: 2009
  end-page: 285
  ident: bib21
  article-title: CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis
  publication-title: Cell
– volume: 296
  start-page: 301
  year: 2002
  end-page: 305
  ident: bib28
  article-title: The danger model: a renewed sense of self
  publication-title: Science
– volume: 15
  start-page: 1879
  year: 2016
  end-page: 1889
  ident: bib62
  article-title: Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells
  publication-title: Mol. Cancer Ther.
– volume: 164
  start-page: 427
  year: 2000
  end-page: 435
  ident: bib40
  article-title: Monocyte migration through the alveolar epithelial barrier: adhesion molecule mechanisms and impact of chemokines
  publication-title: J. Immunol.
– volume: 8
  start-page: 101
  year: 2017
  ident: bib44
  article-title: AGC family kinase 1 participates in trogocytosis but not in phagocytosis in Entamoeba histolytica
  publication-title: Nat. Commun.
– volume: 9
  start-page: 5866
  year: 2003
  end-page: 5873
  ident: bib18
  article-title: Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin’s lymphoma severe combined immunodeficiency mouse model
  publication-title: Clin. Cancer Res.
– volume: 2
  start-page: 63ra94
  year: 2010
  ident: bib8
  article-title: Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47
  publication-title: Sci. Transl. Med.
– volume: 19
  start-page: 6721
  year: 2000
  end-page: 6731
  ident: bib20
  article-title: SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility
  publication-title: EMBO J.
– volume: 109
  start-page: E2843
  year: 2012
  ident: bib67
  article-title: On the mechanism of CD47 targeting in cancer
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 124
  start-page: 5466
  year: 2014
  end-page: 5480
  ident: bib13
  article-title: Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
  publication-title: J. Clin. Invest.
– volume: 123
  start-page: 5098
  year: 2013
  end-page: 5103
  ident: bib31
  article-title: The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging
  publication-title: J. Clin. Invest.
– volume: 51
  start-page: 1293
  year: 2010
  end-page: 1304
  ident: bib43
  article-title: Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models
  publication-title: Leuk. Lymphoma
– volume: 48
  start-page: 53
  year: 2012
  end-page: 61
  ident: bib58
  article-title: Hematologically important mutations: leukocyte adhesion deficiency (first update)
  publication-title: Blood Cells Mol. Dis.
– volume: 161
  start-page: 1035
  year: 2015
  end-page: 1045
  ident: bib11
  article-title: Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
  publication-title: Cell
– volume: 144
  start-page: 3281
  year: 1990
  end-page: 3287
  ident: bib23
  article-title: Analysis of the role of leukocyte function-associated antigen-1 in activation of human influenza virus-specific T cell clones
  publication-title: J. Immunol.
– volume: 119
  start-page: 4333
  year: 2012
  end-page: 4334
  ident: bib66
  article-title: Is targeting of CD47-SIRPα enough for treating hematopoietic malignancy?
  publication-title: Blood
– volume: 23
  start-page: 197
  year: 2005
  end-page: 223
  ident: bib42
  article-title: How neutrophils kill microbes
  publication-title: Annu. Rev. Immunol.
– volume: 15
  start-page: 39
  year: 2015
  ident: bib48
  article-title: Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
  publication-title: BMC Cancer
– volume: 122
  start-page: 109
  year: 2013
  end-page: 111
  ident: bib68
  article-title: Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutations
  publication-title: Blood
– volume: 129
  start-page: 2636
  year: 2017
  end-page: 2644
  ident: bib55
  article-title: Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies
  publication-title: Blood
– volume: 43
  start-page: 764
  year: 2015
  end-page: 775
  ident: bib64
  article-title: Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses
  publication-title: Immunity
– volume: 8
  start-page: 34
  year: 2008
  end-page: 47
  ident: bib33
  article-title: Fcgamma receptors as regulators of immune responses
  publication-title: Nat. Rev. Immunol.
– volume: 118
  start-page: 2098
  year: 2008
  end-page: 2110
  ident: bib41
  article-title: Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
  publication-title: J. Clin. Invest.
– volume: 48
  start-page: 344
  year: 2018
  end-page: 354
  ident: bib53
  article-title: Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody-dependent cellular cytotoxicity towards cancer cells
  publication-title: Eur. J. Immunol.
– volume: 4
  start-page: 815
  year: 2003
  ident: bib22
  article-title: What is trogocytosis and what is its purpose?
  publication-title: Nat. Immunol.
– volume: 23
  start-page: 190
  year: 2013
  end-page: 199
  ident: bib57
  article-title: Neutrophils as effector cells for antibody-based immunotherapy of cancer
  publication-title: Semin. Cancer Biol.
– volume: 16
  start-page: 1646
  year: 2014
  end-page: 1665
  ident: bib14
  article-title: Staphylococcus aureus proteins SSL6 and SElX interact with neutrophil receptors as identified using secretome phage display
  publication-title: Cell. Microbiol.
– volume: 2
  start-page: 748
  year: 2012
  end-page: 755
  ident: bib56
  article-title: SIRPα controls the activity of the phagocyte NADPH oxidase by restricting the expression of gp91(phox)
  publication-title: Cell Rep.
– volume: 97
  start-page: 2478
  year: 2001
  end-page: 2486
  ident: bib60
  article-title: Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation
  publication-title: Blood
– volume: 20
  start-page: 344
  year: 2008
  end-page: 352
  ident: bib5
  article-title: Line of attack: NK cell specificity and integration of signals
  publication-title: Curr. Opin. Immunol.
– volume: 142
  start-page: 699
  year: 2010
  end-page: 713
  ident: bib7
  article-title: Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
  publication-title: Cell
– volume: 12
  start-page: 1084
  year: 2007
  end-page: 1095
  ident: bib47
  article-title: A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects
  publication-title: Oncologist
– volume: 10
  start-page: 568
  year: 2010
  end-page: 579
  ident: bib10
  article-title: Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules
  publication-title: Nat. Rev. Immunol.
– volume: 109
  start-page: E2842
  year: 2012
  end-page: E2845
  ident: bib45
  article-title: Inhibitory signaling through signal regulatory protein-α is not sufficient to explain the antitumor activities of CD47 antibodies
  publication-title: Proc. Natl. Acad. Sci. USA
SSID ssj0000601194
Score 2.6315875
Snippet Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be...
SourceID doaj
proquest
pubmed
elsevier
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 3946
SubjectTerms Animals
Antibodies, Monoclonal - therapeutic use
Antibody-Dependent Cell Cytotoxicity
antibody-dependent cellular cytotoxicity
CD11b Antigen - metabolism
CD18 Antigens - metabolism
CD47 Antigen - metabolism
CD47-SIRPα interaction
Cell Line, Tumor
Female
Humans
Male
Melanoma, Experimental - metabolism
Melanoma, Experimental - pathology
Mice
Mice, Inbred C57BL
Neoplasms - drug therapy
Neoplasms - immunology
Neoplasms - pathology
neutrophils
Neutrophils - immunology
Receptors, IgG - metabolism
Receptors, Immunologic - genetics
Receptors, Immunologic - metabolism
Transplantation, Homologous
trogocytosis
trogoptosis
Title Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
URI https://dx.doi.org/10.1016/j.celrep.2018.05.082
https://www.ncbi.nlm.nih.gov/pubmed/29949776
https://www.proquest.com/docview/2061413688
https://doaj.org/article/949872a446914ec6b8703403d441a789
Volume 23
WOSCitedRecordID wos000436517100023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2211-1247
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9QwEB70UPBF_O1651HB12J_pGnyJOfiISirDyfsW2iSiVaWdmm7wvrXO9PsHueD-OJrCc0wX5Jvhky-AXitfYallCLNdFApnZJ0DnqNaV7ZUGIIUttZMv9TvVqp9Vp_udHqi2vCojxwdNwbLSgrLhrKWnQu0ElLC6wUWemJx5tazU_3slrfSKbiGcxaZnylXBRcs1WI-vhubi7ucrgZkOUqczULd846fDz3H5z0t5hz5p7LB3D_EDQmF9HYh3ALu0dwN7aR3D-GtyvcTUO__d5uxuRju6GR3dTa3u_Tz1zs0f5CnywZ3iFZ4oYG2X1yNfTf-u3Uj-34BL5evr9afkgPjRFST_ttSkvUwSnnS4G6UHyTpqXA4EVTEd_7zOZahzqTLkcZRCWkFzk2SoYMaxGcLJ_CSdd3-BwSXTWOG38Gxz6uioYyKtX4KreSdqe1C3jHbjHbqH1hWI16_kAYmQNG5l8YLaA-OtUciD0SNv2qNcc6sx8momIYFZNVhlBZwKsjBobWPV9mNB32u5EGUWCRl1KpBTyL4FwbSRQrKK6VL_6H8adwjw3i8rBCnsHJNOzwJdxxP6d2HM7hdr1W5_Pi-w0kntdf
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutrophils+Kill+Antibody-Opsonized+Cancer+Cells+by+Trogoptosis&rft.jtitle=Cell+reports+%28Cambridge%29&rft.au=Matlung%2C+Hanke+L&rft.au=Babes%2C+Liane&rft.au=Zhao%2C+Xi+Wen&rft.au=van+Houdt%2C+Michel&rft.date=2018-06-26&rft.issn=2211-1247&rft.eissn=2211-1247&rft.volume=23&rft.issue=13&rft.spage=3946&rft_id=info:doi/10.1016%2Fj.celrep.2018.05.082&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-1247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-1247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-1247&client=summon